Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

被引：0
|
作者：
Qianyu Zhu
Jialing Zhou
Hongyi Li
Hui Wang
Jiangbo Ren
Shujie Sun
Miaoran Yang
Shanshan Wu
Ming Cao
Kaixiang Wang
Hong You
Hong Ma
机构：
[1] Beijing Friendship Hospital,Liver Research Center
[2] Capital Medical University,Molecular Biology Laboratory
[3] National Clinical Research Center for Digestive Diseases,undefined
[4] Baoding People’s Hospital,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Biomarker; Hepatocellular carcinoma; Liver cirrhosis; Antiviral agent; Diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12691 / 12701
页数：10
相关论文
共 50 条
  • [41] Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
    Papatheodoridis, George V.
    Lampertico, Pietro
    Manolakopoulos, Spilios
    Lok, Anna
    JOURNAL OF HEPATOLOGY, 2010, 53 (02) : 348 - 356
  • [42] Prognostic MicroRNA Fingerprints Predict Recurrence of Early-Stage Hepatocellular Carcinoma Following Hepatectomy
    Wong, Victor Chun -Lam
    Wong, Ming-In
    Lee, Victor Ho-Fun
    Man, Kwan
    Ng, Kevin Tak-Pan
    Cheung, Tan To
    JOURNAL OF CANCER, 2023, 14 (03): : 480 - 489
  • [43] Comparison of risk prediction model for hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis receiving antiviral therapy
    Suh, Sang Jun
    Yim, Hyung Joon
    Lee, Young-Sun
    Lee, Han Ah
    Kim, Tae Hyung
    Yim, Sun Young
    Jung, Young Kul
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yeon, Jong Eun
    Byun, Kwan Soo
    Um, Soon Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 437 - 437
  • [44] Early-stage hepatocellular carcinoma screening in patients with chronic hepatit B in China: a cost-effectiveness analysis is
    Nan, Yuemin
    Garay, Osvaldo Ulises
    Lu, Xianzhong
    Zhang, Yue
    Xie, Li
    Niu, Zhongyi
    Chen, Wen
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (04) : e230146
  • [45] Role of ablation: should it be used as primary therapy for early-stage hepatocellular carcinoma?
    Pompili, Maurizio
    Francica, Giampiero
    HEPATIC ONCOLOGY, 2015, 2 (04) : 339 - 342
  • [46] Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma
    Lee, Shou-Wu
    Chen, Li-Shu
    Yang, Sheng-Shun
    Huang, Yi-Hsiang
    Lee, Teng-Yu
    VIRUSES-BASEL, 2022, 14 (11):
  • [47] MeCP2 level is associated with hepatocellular carcinoma development in chronic hepatitis B patients under antiviral therapy
    Li, Yun
    Zhu, Qian
    Tang, Jie
    Guo, De-Liang
    Duan, Rui
    Liu, Jian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1356 - 1364
  • [48] Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred?
    van Erpecum, Karel J.
    Sonneveld, Milan J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 27 - 29
  • [49] Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment
    Kirino, Sakura
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Inada, Kento
    Yamashita, Koji
    Sekiguchi, Shuhei
    Hayakawa, Yuka
    Osawa, Leona
    Higuchi, Mayu
    Takaura, Kenta
    Maeyashiki, Chiaki
    Kaneko, Shun
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Izumi, Namiki
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (05) : 787 - 794
  • [50] A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Zhu, Lihui
    Li, Tao
    Ma, Xiaomin
    Qiu, Yumin
    Ma, Xiaoxiao
    Lin, Yueke
    Han, Lihui
    Qin, Chengyong
    SCIENTIFIC REPORTS, 2017, 7
12345